The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-α messenger RNA levels in the inflamed tissue of the rat paw

Anesthesia and Analgesia

Volumn 98, Issue 6, 2004, Pages 1566-1573

  Dorazil Dudzik, Magdalena ^a   Mika, Joanna ^b,c   Schafer, Martin K H ^c   Li, Yanzhang ^c   Obara, Ilona ^b   Wordliczek, Jerzy ^a   Przewłocka, Barbara ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PENTOXIFYLLINE; PROPENTOFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; RAT; SPLEEN;

EID: 2442716627     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000113235.88534.48     Document Type: Article

References (30)

1. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990;346:274-6.
2. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660-4.
3. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 1997;121:417-24.
4. Oka T, Oka K, Hosoi M, Hori T. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res 1995;692:123-8.
5. Watkins LR, Goehler LE, Relton J, et al. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 1995;692:244-50.
6. Perkins MN, Kelly D, Davis AJ. Bradykinin B1 and B2 receptor mechanisms and cytokine-induced hyperalgesia in the rat. Can J Physiol Pharmacol 1995;73:832-6.
7. Hua XY, Chen P, Fox A, Myers RR. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1beta and tumor necrosis factor-alpha. J Neurosci 1996;16:4742-8.
8. Watkins LR, Wiertelak EP, Goehler LE, et al. Characterization of cytokine-induced hyperalgesia. Brain Res 1994;654:15-26.
9. Neuner P, Klosner G, Schauer E, et al. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 1994;83:262-7.
10. Semmler J, Gebert U, Eisenhut T, et al. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 1993;78:520-5.
11. Zabel P, Schade FU, Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993;187:447-63.
12. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-4.
13. Wordliczek J, Szczepanik AM, Banach M, et al. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci 2000;66:155-64.
14. Coderre TJ, Fundytus ME, McKenna JE, et al. The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain 1993;54:43-50.
15. Goto T, Marota JJ, Crosby G. Nitrous oxide induces preemptive analgesia in the rat that is antagonized by halothane. Anesthesiology 1994;80:409-16.
16. Schafer MK, Day R, Cullinan WE, et al. Gene expression of prohormone and protein convertases in the rat CNS: a comparative in situ hybridization analysis. J Neurosci 1993;13:1258-79.
17. Sweitzer SM, Colburn RW, Rutkowski M, DeLeo JA. Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat. Brain Res 1999;829:209-21.
18. Watkins LR, Martin D, Ulrich P, et al. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997;71:225-35.
19. Sweitzer SM, Schubert P, DeLeo JA. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 2001;297:1210-7.
20. Dominguez-Jimenez C, Sancho D, Nieto M, et al. Effect of pentoxifylline on polarization and migration of human leukocytes. J Leukoc Biol 2002;71:588-96.
21. Cocchiara R, Lampiasi N, Albeggiani G, et al. Mast cell production of TNF-alpha induced by substance P evidence for a modulatory role of substance P-antagonists. J Neuroimmunol 1999;101:128-36.
22. Biedermann T, Kneilling M, Mailhammer R, et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000;192:1441-52.
23. Tjolsen A, Berge O, Hunskaar S, et al. The formalin test: an evaluation of the method. Pain 1992;51:5-17.
24. Dickenson AH, Sullivan AF. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 1987;30:349-60.
25. Herbert MK, Holzer P. Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br J Pharmacol 1994;111:681-6.
26. Otamiri L, Franzen L, Lindmark L, Tagesson C. Increased phospholipase A2 and decreased phospholipase activity in the small intestinal mucosa after ischemia and revascularisation. Gut 1987;28:1445-53.
27. Meskini N, Nemoz G, Okyayuz-Baklouti L et al. Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem Pharmacol 1994;47:781-8.
28. Platzer C, Fritsch E, Elsner T, et al. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur J Immunol 1999;29:3098-104.
29. Wagner R, Janjigian M, Myers RR. Anti-inflammatory IL-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNFα expression. Pain 1998;74:35-42.
30. Rodella L, Rezzani R, Gioia M, et al. Expression of Fos immunoreactivity in the rat supraspinal regions following noxious visceral stimulation. Brain Res Bull 1998;47:357-66.